News 
Market Data 
Discover
Replies to post #88267 on Magic
From @MayoPCCM and @MayoClinicINFD faculty: In #COVID19 pts w/ severe pneumonia, GM-CSF neutralization with lenzilumab was safe and associated with faster clinical improvement compared w/ a control cohort. A RCT to validate these findings is ongoing https://t.co/Hkk3s1rhsU
— MayoPCCM (@MayoPCCM) November 10, 2020
